TrialThe British journal of dermatology2013

A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis.

W C Ports et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.